Probiotics in the treatment and prevention of atopic dermatitis

Annals of Nutrition and Metabolism

Volumn 57, Issue SUPPL. 1, 2010, Pages 16-19

  Folster Holst R ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ATOPIC DERMATITIS; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM LONGUM; CLINICAL TRIAL; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; HUMANS; INFANT; PRIMARY PREVENTION; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77956548369     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000309054     Document Type: Short Survey

References (37)

1. Strachan DP: Family size, infection and atopy: the first decade of the 'hygiene hypothesis'. Thorax 2000; 55(suppl 1):S2-S10.
2. Ou LS, Goleva E, Hall C, Leung DY: T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 20 04; 11 3: 756-763.
3. Isolauri E, Kalliomäki M, Laitinen K, Sal-minen S: Modulation of the maturino gut barrier and microbiotica: a novel target in allergic disease. Curr Pharm Des 2008; 14: 136 8-1375.
4. Rosenfeldt V, Benfeldt E, Valerius NH, Paer-regaard A, Michaelsen KF: Effect of probiot-ics on gastrointestinal symptoms and small intestinal permeability in children with atop-ic dermatitis. J Pediatr 2004; 145: 612-616.
5. Pochard P, Gosset P, Grangette C, Andre C, Tonnel A B, Pestel J, Mercenier A: Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J A l lerg y Clin Immunol 2002; 110: 617-6 2 3.
6. Ghadimi D, Fölster-Holst R, De Vrese M, Winkler P, Heller KJ, Schrezenmeir J: Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobi-ology 2008; 213:677-692.
7. Hacini-Rachinel F, Gheit H, Le Luduec JB, Dif F, Nancey S, Kaiserlian D: Ora l probiotic cont rol sk i n i nf l a m mat ion by ac t i ng on bot h effector and regulatory T cells. PLoS One 2009; 4:e4903.
8. Mastrangeli G, Corinti S, Butteroni C, Af-ferni C, Bonura A, Boirivant M, Colombo P, Di Felice G: Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses. Int Arch Allergy Immunol 2009; 150: 133-143.
9. Smits HH, Engering A, van Der Kleij D, De Jong EC, Schipper K, van Capel TM, Zaat BA, Yazdanbakhsh M, Wierenga EA, van Kooyk Y, Kapsenberg ML: Selective probi-otic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005; 115:1260-1267.
10. Schmidt EG, Claesson MH, Jensen SS, Ravn P, Kristensen NN: Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity. Inflamm Bowel Dis 2010; 16: 390-400.
11. Majamaa H, Isolauri E: Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997; 99:179-185.
12. Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357: 1076-1079.
13. Kalliomäki M, Salminen S, Poussa T, Ar-vilommi H, Isolauri E: Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361:1869-1871.
14. Kalliomäki M, Salminen S, Poussa T, Iso-lauri E: Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119: 1019-1021.
15. Van Der Aa LB, Heymans HS, van Aalderen WM, Sprikkelman AB: Probiotics and prebi-otics in atopic dermatitis: review of the theoretical background and clinical evidence. Pe-diatr Allergy Immunol 2009, Epub ahead of print.
16. Betsi GI, Papadavid E, Falagas ME: Probiot-ics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol 2008; 9: 93-103.
17. Fölster-Holst R, Offick B, Proksch E, Schrez enmei r J: Probiotic s i n t reat ment a nd/or prevention of a l lerg ies; in Micha il S, Sherman PM (eds): Probiotics in Pediatric Medicine. Totowa, Humana Press, Springer, 2009, 243-267.
18. Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B, Oldaeus G: Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1174-1180.
19. Kukkonen K, Savilahti E, Haahtela T, Jun-tunen-Backman K, Korpela R, Poussa T, Tu-ure T, Kuitunen M: Probiotics and prebiotic galacto- oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007; 11 9: 192-198.
20. Taylor AL, Dunstan JA, Prescott SL: Probi-otic supplementation for the first 6 months of l i fe fa i l s to reduce t he r i s k of atopic Der m a-titis and increases the risk of allergen sensi-tization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 11 9: 18 4-191.
21. Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, Purdie G, Crane J, Probiotic Study Group: A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008; 122:788-794.
22. Kopp MV, Hennemuth I, Heinzmann A, Ur-banek R: Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacil-lus GG supplementation. Pediatrics 2008; 121:e850-e856.
23. Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO, Lee SY, Ahn KM, Ji GE: Effect of probiotic mix (Bifidobacterium bifidum, Bi-fidobacterium lactis, Lactobacillus acidophi-lus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2009, Epub ahead of print.
24. Niers L, Martín R, Rijkers G, Sengers F, Tim-merman H, van Uden N, Smidt H, Kimpen J, Hoekstra M: The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009; 64:1349-1358.
25. Soh SE, Aw M, Gerez I, Chong YS, Rauff M, Ng YP, Wong HB, Pai N, Lee BW, Shek LP: Probiotic supplementation in the first 6 months of life in at risk Asian infants-effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy 2009; 39: 571-578.
26. Kirjavainen PV, Salminen SJ, Isolauri E: Pro-biotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003; 36: 223-227.
27. Rosenfeldt V, Benfeldt E, Nielsen SD, Mi-chaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A: Effect of probiotic Lactoba-cillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111: 389-395.
28. Weston S, Halbert A, Richmond P, Prescott SL: Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005; 90:892-897.
29. Viljanen M, Savilahti E, Haahtela T, Jun-tunen-Backman K, Korpela R, Poussa T, Tu-ure T, Kuitunen M: Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005; 60:494-500.
30. Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, Crane J: Is the effect of probiot-ics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy 2006; 36: 629-633.
31. Brouwer ML, Wolt-Plompen SAA, Dubois AEJ, van Der Heide S, Jansen DJ, Hoijer MA, Kauffman HF, Duiverman EJ: No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006; 36:899-906.
32. Passeron T, Lacour JP, Fontas E, Ortonne JP: Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 2006; 61:431-437.
33. Fölster-Holst R, Müller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T, von Rüden U, Schrezenmeir J, Christophers E, Weichen-thal M: Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 2006; 155:1256-1261.
34. Grüber C, Wendt M, Sulser C, Lau S, Kulig M, Wahn U, Werfel T, Niggemann B: Randomized, placebo-controlled trial of Lacto-bacillus rhamnosus GG as treat ment of atop-ic dermatitis in infancy. Allergy 2007; 62: 1270-1276.
35. Osborn DA, Sinn JK: Probiotics in infants for prevention of allergic disease and food hy-persensitivity. Cochrane Database Syst Rev 2007 Oct 17;CD006475.
36. Lee J, Seto D, Bielory L: Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Al-lerg y Clin Immunol 2008; 121: 116-121.e11.
37. Rautava S, Isolauri E: The development of gut immune responses and gut microbiota: effects of probiotics in prevention and treatment of allergic disease. Curr Issues Intest Microbiol 2002; 3:15-22.